ProPhase Labs, Inc. 4/A
4/A · ProPhase Labs, Inc. · Filed Dec 8, 2015
Insider Transaction Report
Form 4/AAmended
Leventhal Mark S
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0005
2015-11-25$1.30/sh+17,252$22,428→ 867,732 total - Purchase
Common Stock, par value $0.0005
2015-11-24$1.30/sh+18,500$24,050→ 850,480 total
Footnotes (3)
- [F1]This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 25, 2015.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.